FDA approves Abilify tablets with ingestible sensor

Late Monday, FDA approved Abilify MyCite, which combines the antipsychotic Abilify aripiprazole from Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) with an ingestible sensor from

Read the full 248 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE